Treatment for and Clinical Characteristics of Granulomatous Mastitis

Obstetrics and Gynecology

Volumn 126, Issue 2, 2015, Pages 449-

  Avci, Muhittin Eftal ^a   Arslan, Ferhat ^b   Basim, Pelin ^b  

^a Kanuni Sultan Suleyman Education and Research Hospital   (Turkey)

^b ISTANBUL MEDIPOL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DOXYCYCLINE; METHOTREXATE; STEROID; TEICOPLANIN; ANTIINFLAMMATORY AGENT; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

ADULT; ANTIBIOTIC THERAPY; CORYNEBACTERIUM; DIFFERENTIAL DIAGNOSIS; FEMALE; GRANULOMATOUS MASTITIS; HUMAN; LETTER; MASTITIS; PRIORITY JOURNAL; RECURRENCE RISK; STEROID THERAPY; TREATMENT DURATION; TREATMENT OUTCOME; TUBERCULIN TEST; TUBERCULOSIS;

ANTI-INFLAMMATORY AGENTS; FEMALE; GRANULOMATOUS MASTITIS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; METHOTREXATE; PREDNISONE;

EID: 84937680679     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000000984     Document Type: Letter

References (3)

1. Pereira FA, Mudgil AV, Macias ES, Karsif K. Idiopathic granulomatous lobular mastitis. Int J Dermatol 2012;51: 142-51.
2. Sheybani F, Sarvghad M, Naderi H, Gharib M. Treatment for and clinical characteristics of granulomatous mastitis. Obstet Gynecol 2015;125:801-7.
3. Taylor GB, Paviour SD, Musaad S, Jones WO, Holland DJ. A clinicopathological review of 34 cases of inflammatory breast disease showing an association between Corynebacterium infection and granulomatous mastitis. Pathology 2003;35:109-19.